MESSAGE
| DATE | 2021-10-21 |
| FROM | Pharma Update News Service
|
| SUBJECT | Subject: [Hangout - NYLXS] WHITEPAPER: Automation and Data Analytics in
|
From hangout-bounces-at-nylxs.com Thu Oct 21 22:42:14 2021
Return-Path:
X-Original-To: archive-at-mrbrklyn.com
Delivered-To: archive-at-mrbrklyn.com
Received: from www2.mrbrklyn.com (www2.mrbrklyn.com [96.57.23.82])
by mrbrklyn.com (Postfix) with ESMTP id CA438164047;
Thu, 21 Oct 2021 22:42:13 -0400 (EDT)
X-Original-To: hangout-at-www2.mrbrklyn.com
Delivered-To: hangout-at-www2.mrbrklyn.com
Received: by mrbrklyn.com (Postfix, from userid 1000)
id 46639164047; Thu, 21 Oct 2021 22:42:11 -0400 (EDT)
Resent-From: Ruben Safir
Resent-Date: Thu, 21 Oct 2021 22:42:11 -0400
Resent-Message-ID: <20211022024211.GB9408-at-www2.mrbrklyn.com>
Resent-To: hangout-at-mrbrklyn.com
X-Original-To: ruben-at-mrbrklyn.com
Delivered-To: ruben-at-mrbrklyn.com
Received: from ccm236.constantcontact.com (ccm236.constantcontact.com
[208.75.123.236]) by mrbrklyn.com (Postfix) with ESMTP id 93617164038
for ; Thu, 21 Oct 2021 13:22:54 -0400 (EDT)
Received: from [10.252.0.2] ([10.252.0.2:46114]
helo=p2-jbemailsyndicator23.ctct.net) by 10.249.228.10 (envelope-from
)
(ecelerity 4.3.1.69410 r(Core:4.3.1.0)) with ESMTP
id 6B/94-23686-0E1A1716; Thu, 21 Oct 2021 13:22:40 -0400
DKIM-Signature: v=1; q=dns/txt; a=rsa-sha256; c=relaxed/relaxed; s=1000073432;
d=auth.ccsend.com;
h=date:mime-version:subject:X-Feedback-ID:X-250ok-CID:message-id:from:reply-to:list-unsubscribe:list-unsubscribe-post:to;
bh=85zh+mZ3U3hggeMQXqIW4WBSLZ8FZ4P6++G3aPXlpQ4=;
b=YUUih9bAA90yrxbItz4p71j/o3e6b/EB3jJFX+8HB4ml1atiTiH61jQ4mKA9UrMfkfXyGWgs6SPQQwfgktPGaFx6wr5mRz72u5CF3y6ARVyaycqH3mFmzd+BwcfQN5k5b0TLJtv4s7fJCv3M4UoSGyBHc8m/ZnU+81ybxBHVDHA=
Message-ID: <1137821697164.1011231382206.8254.0.131322JL.2002-at-scheduler.constantcontact.com>
Date: Thu, 21 Oct 2021 13:22:40 -0400 (EDT)
From: Pharma Update News Service
To: ruben-at-mrbrklyn.com
MIME-Version: 1.0
List-Unsubscribe-Post: List-Unsubscribe=One-Click
X-Campaign-Activity-ID: a46e79b8-c50c-4c6a-8525-ac45d9140c25
X-250ok-CID: a46e79b8-c50c-4c6a-8525-ac45d9140c25
X-Channel-ID: 83ca7740-320b-11e3-b3ee-d4ae527b8c41
X-Mailer: Roving Constant Contact 2012 (http://www.constantcontact.com)
X-Return-Path-Hint: ApG55uMUMTGqFJaxF2RQMJQ==_1011231382206_g8p3QDILEeOz7tSuUnuMQQ==-at-in.constantcontact.com
X-Roving-Campaignid: 1137821697164
X-Roving-Id: 1011231382206.8254
X-Feedback-ID: 83ca7740-320b-11e3-b3ee-d4ae527b8c41:a46e79b8-c50c-4c6a-8525-ac45d9140c25:1011231382206:CTCT
X-CTCT-ID: 82e32480-320b-11e3-b31d-d4ae527b8c41
Subject: [Hangout - NYLXS] WHITEPAPER: Automation and Data Analytics in
Third-Party Risk Management
X-BeenThere: hangout-at-nylxs.com
X-Mailman-Version: 2.1.30rc1
Precedence: list
List-Id: NYLXS Tech Talk and Politics
List-Unsubscribe: ,
List-Archive:
List-Post:
List-Help:
List-Subscribe: ,
Reply-To: admin-at-pharmaupdatenewsservice.com
Content-Type: multipart/mixed; boundary="===============0241522740=="
Errors-To: hangout-bounces-at-nylxs.com
Sender: "Hangout"
--===============0241522740==
Content-Type: multipart/alternative;
boundary="----=_Part_535424680_2121733603.1634836960795"
------=_Part_535424680_2121733603.1634836960795
Content-Type: text/plain; charset=utf-8
Content-Transfer-Encoding: quoted-printable
WHITEPAPER: Automation and Data Analytics in Third-Party Risk Management WH=
ITEPAPER: Automation and Data Analytics in Third-Party Risk Management NEW =
YORK, NY USA -- PHARMA UPDATE NEWS SERVICE -- OCTOBER 21, 2021: Ethics and =
compliance leaders working in the life sciences sector face an increasingly=
complex set of responsibilities. Risks associated with third parties =E2=
=80=94 corruption, bribery, and other forms of illegal activity =E2=80=94 o=
ffer a particular challenge. The latest U.S. Department of Justice (DOJ) gu=
idance for the Evaluation of Corporate Compliance Programs (June 2020) make=
s clear that data analytics are critical to a successful ethics and complia=
nce program. But where do you begin? And what should you address? This whit=
epaper specifies how Automation and Data Analytics can help organizations o=
vercome the challenges of mitigating Third-Party Risk. In partnership with =
Ethisphere's BELA Data Analytics Working Group, Lextegrity joined 27 leadin=
g ethics and compliance experts to explore what a best practice approach to=
data analytics and automation in third-party risk management looks like. T=
his resulting whitepaper highlights: Core challenges organizations face in =
mitigating third-party risk How automation and analytics can help Ways to o=
vercome common pain points in existing processes and workflows You can down=
load the whitepaper here. ABOUT LEXTEGRITY Lextegrity provides software tha=
t helps organizations monitor spend, automate third-party due diligence and=
simplify compliance pre-approvals. It was founded and is led by legal and =
audit professionals from the life sciences sector, who built the risk manag=
ement tools they wished they'd had when they were in-house. Lextegrity's so=
ftware is used by multiple life sciences companies including Alexion, Frese=
nius and Lifescan. FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS: For c=
hanges or additions, please email your request to: listmgr-at-PharmaUpdateNews=
Service.com. For removal of your e-mail address, please click the "SafeUnsu=
bscribe" link located in the footer of this message below to automatically =
remove your address from the list. Lextegrity | 208 E 51st Street, New York=
, NY 10022 Unsubscribe ruben-at-mrbrklyn.com Update Profile | Constant Contact=
Data Notice Sent by admin-at-pharmaupdatenewsservice.com powered by Try email=
marketing for free today!
------=_Part_535424680_2121733603.1634836960795
Content-Type: text/html; charset=utf-8
Content-Transfer-Encoding: 7bit
WHITEPAPER: Automation and Data Analytics in Third-Party Risk Management<BR>
|
|
WHITEPAPER: Automation and Data Analytics in Third-Party Risk Management
|
NEW YORK, NY USA -- PHARMA UPDATE NEWS SERVICE -- OCTOBER 21, 2021: Ethics and compliance leaders working in the life sciences sector face an increasingly complex set of responsibilities. Risks associated with third parties — corruption, bribery, and other forms of illegal activity — offer a particular challenge.
The latest U.S. Department of Justice (DOJ) guidance for the Evaluation of Corporate Compliance Programs (June 2020) makes clear that data analytics are critical to a successful ethics and compliance program.
But where do you begin? And what should you address?
This whitepaper specifies how Automation and Data Analytics can help organizations overcome the challenges of mitigating Third-Party Risk.
In partnership with Ethisphere's BELA Data Analytics Working Group, Lextegrity joined 27 leading ethics and compliance experts to explore what a best practice approach to data analytics and automation in third-party risk management looks like. This resulting whitepaper highlights:
- Core challenges organizations face in mitigating third-party risk
- How automation and analytics can help
- Ways to overcome common pain points in existing processes and workflows
You can download the whitepaper here.
ABOUT LEXTEGRITY
Lextegrity provides software that helps organizations monitor spend, automate third-party due diligence and simplify compliance pre-approvals. It was founded and is led by legal and audit professionals from the life sciences sector, who built the risk management tools they wished they'd had when they were in-house. Lextegrity's software is used by multiple life sciences companies including Alexion, Fresenius and Lifescan.
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS:
For changes or additions, please email your request to: listmgr-at-PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the "SafeUnsubscribe" link located in the footer of this message below to automatically remove your address from the list.
|
|
------=_Part_535424680_2121733603.1634836960795--
--===============0241522740==
Content-Type: text/plain; charset="us-ascii"
MIME-Version: 1.0
Content-Transfer-Encoding: 7bit
Content-Disposition: inline
_______________________________________________
Hangout mailing list
Hangout-at-nylxs.com
http://lists.mrbrklyn.com/mailman/listinfo/hangout
--===============0241522740==--
--===============0241522740==
Content-Type: multipart/alternative;
boundary="----=_Part_535424680_2121733603.1634836960795"
------=_Part_535424680_2121733603.1634836960795
Content-Type: text/plain; charset=utf-8
Content-Transfer-Encoding: quoted-printable
WHITEPAPER: Automation and Data Analytics in Third-Party Risk Management WH=
ITEPAPER: Automation and Data Analytics in Third-Party Risk Management NEW =
YORK, NY USA -- PHARMA UPDATE NEWS SERVICE -- OCTOBER 21, 2021: Ethics and =
compliance leaders working in the life sciences sector face an increasingly=
complex set of responsibilities. Risks associated with third parties =E2=
=80=94 corruption, bribery, and other forms of illegal activity =E2=80=94 o=
ffer a particular challenge. The latest U.S. Department of Justice (DOJ) gu=
idance for the Evaluation of Corporate Compliance Programs (June 2020) make=
s clear that data analytics are critical to a successful ethics and complia=
nce program. But where do you begin? And what should you address? This whit=
epaper specifies how Automation and Data Analytics can help organizations o=
vercome the challenges of mitigating Third-Party Risk. In partnership with =
Ethisphere's BELA Data Analytics Working Group, Lextegrity joined 27 leadin=
g ethics and compliance experts to explore what a best practice approach to=
data analytics and automation in third-party risk management looks like. T=
his resulting whitepaper highlights: Core challenges organizations face in =
mitigating third-party risk How automation and analytics can help Ways to o=
vercome common pain points in existing processes and workflows You can down=
load the whitepaper here. ABOUT LEXTEGRITY Lextegrity provides software tha=
t helps organizations monitor spend, automate third-party due diligence and=
simplify compliance pre-approvals. It was founded and is led by legal and =
audit professionals from the life sciences sector, who built the risk manag=
ement tools they wished they'd had when they were in-house. Lextegrity's so=
ftware is used by multiple life sciences companies including Alexion, Frese=
nius and Lifescan. FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS: For c=
hanges or additions, please email your request to: listmgr-at-PharmaUpdateNews=
Service.com. For removal of your e-mail address, please click the "SafeUnsu=
bscribe" link located in the footer of this message below to automatically =
remove your address from the list. Lextegrity | 208 E 51st Street, New York=
, NY 10022 Unsubscribe ruben-at-mrbrklyn.com Update Profile | Constant Contact=
Data Notice Sent by admin-at-pharmaupdatenewsservice.com powered by Try email=
marketing for free today!
------=_Part_535424680_2121733603.1634836960795
Content-Type: text/html; charset=utf-8
Content-Transfer-Encoding: 7bit
WHITEPAPER: Automation and Data Analytics in Third-Party Risk Management<BR>
|
|
WHITEPAPER: Automation and Data Analytics in Third-Party Risk Management
|
NEW YORK, NY USA -- PHARMA UPDATE NEWS SERVICE -- OCTOBER 21, 2021: Ethics and compliance leaders working in the life sciences sector face an increasingly complex set of responsibilities. Risks associated with third parties — corruption, bribery, and other forms of illegal activity — offer a particular challenge.
The latest U.S. Department of Justice (DOJ) guidance for the Evaluation of Corporate Compliance Programs (June 2020) makes clear that data analytics are critical to a successful ethics and compliance program.
But where do you begin? And what should you address?
This whitepaper specifies how Automation and Data Analytics can help organizations overcome the challenges of mitigating Third-Party Risk.
In partnership with Ethisphere's BELA Data Analytics Working Group, Lextegrity joined 27 leading ethics and compliance experts to explore what a best practice approach to data analytics and automation in third-party risk management looks like. This resulting whitepaper highlights:
- Core challenges organizations face in mitigating third-party risk
- How automation and analytics can help
- Ways to overcome common pain points in existing processes and workflows
You can download the whitepaper here.
ABOUT LEXTEGRITY
Lextegrity provides software that helps organizations monitor spend, automate third-party due diligence and simplify compliance pre-approvals. It was founded and is led by legal and audit professionals from the life sciences sector, who built the risk management tools they wished they'd had when they were in-house. Lextegrity's software is used by multiple life sciences companies including Alexion, Fresenius and Lifescan.
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS:
For changes or additions, please email your request to: listmgr-at-PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the "SafeUnsubscribe" link located in the footer of this message below to automatically remove your address from the list.
|
|
------=_Part_535424680_2121733603.1634836960795--
--===============0241522740==
Content-Type: text/plain; charset="us-ascii"
MIME-Version: 1.0
Content-Transfer-Encoding: 7bit
Content-Disposition: inline
_______________________________________________
Hangout mailing list
Hangout-at-nylxs.com
http://lists.mrbrklyn.com/mailman/listinfo/hangout
--===============0241522740==--
|
|
